Latest article
Section III Trial Reveals Lilly’s Tirzepatide is Superior to Rival in Kind 2 Diabetes
Jonathan Weiss / Shutterstock
Eli Lillys The Phase III SURPASS 2 clinical trial shows treatment with tirzepatide, a once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like...
Pequot Nation Exhibits Promising Diabetes Outcomes with Telehealth
By Victoria Bailey
The Mashantucket Pequot Tribal Nation did shown significant positive results for A1c reduction, weight loss and reduced...
Trending Information: Important Oils Market Updates, Dynamics, Aggressive Panorama
InsightSLICE is a leading global research firm is pleased to announce its new report on the Essential Oils Market. The report provides a...